{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:43:34Z","timestamp":1790520214697,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-25-00129"],"award-info":[{"award-number":["14-25-00129"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.clcc.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:12:01Z","timestamp":1539648721000},"page":"e74-e86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity"],"prefix":"10.1016","volume":"18","author":[{"given":"Irina","family":"Druzhkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda","family":"Ignatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Prodanets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-1321","authenticated-orcid":false,"given":"Nikolay","family":"Kiselev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliya","family":"Zhukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Shirmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Zagainov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zagaynova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2018.10.003_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2018.10.003_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834015614530","article-title":"Pharmacologic resistance in colorectal cancer: a review","volume":"8","author":"Hammond","year":"2016","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.clcc.2018.10.003_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/14737140.8.5.683","article-title":"Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer","volume":"8","author":"Beatty","year":"2008","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1016\/j.clcc.2018.10.003_bib4","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/bjc.2011.449","article-title":"Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells","volume":"105","author":"Bose","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2018.10.003_bib5","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2018.10.003_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3892\/ol.2013.1187","article-title":"Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer","volume":"5","author":"Nakamoto","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clcc.2018.10.003_bib7","doi-asserted-by":"crossref","first-page":"16398","DOI":"10.3748\/wjg.v20.i44.16398","article-title":"Recent applications of chemosensitivity tests for colorectal cancer treatment","volume":"20","author":"Yoon","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2018.10.003_bib8","doi-asserted-by":"crossref","first-page":"E965","DOI":"10.3390\/molecules21070965","article-title":"Targeting epithelial\u2013mesenchymal transition (EMT) to overcome drug resistance in cancer","volume":"21","author":"Du","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.clcc.2018.10.003_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.2009.24.6116","article-title":"Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer","volume":"28","author":"Bardelli","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2018.10.003_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.clcc.2018.10.003_bib11","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.3748\/wjg.v22.i30.6764","article-title":"Systematic review of the old and new concepts in the epithelial\u2013mesenchymal transition of colorectal cancer","volume":"22","author":"Gurzu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2018.10.003_bib12","first-page":"10534","article-title":"Down-regualtion of miR-106b induces epithelial\u2013mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer","volume":"8","author":"Zheng","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clcc.2018.10.003_bib13","first-page":"3812","article-title":"Diagnostic and prognostic significance of E-cadherin and Ki-67 expression in non\u2013small cell lung cancer patients","volume":"20","author":"He","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clcc.2018.10.003_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial\u2013mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clcc.2018.10.003_bib15","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"1315","article-title":"Chemotherapy of neoplastic disease","author":"Chabner","year":"2006"},{"key":"10.1016\/j.clcc.2018.10.003_bib16","first-page":"3547","article-title":"Identification of nonproliferating but viable hypoxic tumor cells in\u00a0vivo","volume":"58","author":"Durand","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2018.10.003_bib17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/hep.28755","article-title":"Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling","volume":"64","author":"Ma","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clcc.2018.10.003_bib18","first-page":"693","article-title":"E-cadherin\u2013dependent intercellular adhesion enhances chemoresistance","volume":"12","author":"Nakamura","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clcc.2018.10.003_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.celrep.2016.06.043","article-title":"Anti-M\u00fcllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer","volume":"16","author":"Beck","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.clcc.2018.10.003_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1080\/15384047.2016.1219815","article-title":"Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: role of microRNA-210","volume":"17","author":"Bigagli","year":"2016","journal-title":"Cancer Biol Ther"},{"issue":"14 pt 1","key":"10.1016\/j.clcc.2018.10.003_bib21","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1158\/1078-0432.CCR-06-0038","article-title":"Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines","volume":"12","author":"Yang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2018.10.003_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910500502","article-title":"Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells","volume":"50","author":"Dimanche-Boitrel","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2018.10.003_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00001622-199711000-00010","article-title":"Cell adhesion and drug resistance in cancer","volume":"9","author":"St Croix","year":"1997","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clcc.2018.10.003_bib24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.clcc.2018.10.003_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibtech.2013.03.006","article-title":"Technologies for deriving primary tumor cells for use in personalized cancer therapy","volume":"31","author":"Mitra","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.clcc.2018.10.003_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.gastro.2011.03.052","article-title":"Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan","volume":"141","author":"Emmink","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2018.10.003_bib27","series-title":"Colon Cancer Stem Cells","author":"Kreso","year":"2007"},{"key":"10.1016\/j.clcc.2018.10.003_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3892\/ijmm.2016.2730","article-title":"Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin","volume":"38","author":"Zhang","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clcc.2018.10.003_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djq569","article-title":"The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer","volume":"103","author":"Baker","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2018.10.003_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2184.2007.00433.x","article-title":"Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis","volume":"40","author":"Rahmanzadeh","year":"2007","journal-title":"Cell Prolif"},{"key":"10.1016\/j.clcc.2018.10.003_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jjco\/hyp065","article-title":"The predictive role of E-cadherin and androgen receptor on in\u00a0vitro chemosensitivity in triple-negative breast cancer","volume":"39","author":"Koo","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clcc.2018.10.003_bib32","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1038\/oncsis.2015.17","article-title":"An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt\/\u03b2-catenin-elicited promotion of the cancer stem cell phenotype","volume":"4","author":"Su","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.clcc.2018.10.003_bib33","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3390\/ijms13021632","article-title":"Analysis of Snail-1, E-cadherin and claudin-1 expression in colorectal adenomas and carcinomas","volume":"13","author":"Bezdekova","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clcc.2018.10.003_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/cdd.2015.133","article-title":"DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53","volume":"23","author":"Alam","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clcc.2018.10.003_bib35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3892\/ijo.2016.3342","article-title":"Twist mediates an aggressive phenotype in human colorectal cancer cells","volume":"48","author":"Deng","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clcc.2018.10.003_bib36","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1007\/s13277-015-4755-6","article-title":"Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells","volume":"37","author":"Lv","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.clcc.2018.10.003_bib37","doi-asserted-by":"crossref","first-page":"13854","DOI":"10.18632\/oncotarget.7351","article-title":"Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells","volume":"7","author":"Suman","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clcc.2018.10.003_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1248\/bpb.b14-00695","article-title":"Induction of epithelial\u2013mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells","volume":"38","author":"Tanaka","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.clcc.2018.10.003_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1158\/0008-5472.CAN-06-0594","article-title":"Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features","volume":"67","author":"Dangles-Marie","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.clcc.2018.10.003_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.bjc.6605173","article-title":"Newly characterised ex\u00a0vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness","volume":"101","author":"Weiswald","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2018.10.003_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.3418","article-title":"Self-renewal as a therapeutic target in human colorectal cancer","volume":"20","author":"Kreso","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.clcc.2018.10.003_bib42","doi-asserted-by":"crossref","first-page":"e0183074","DOI":"10.1371\/journal.pone.0183074","article-title":"Short-term spheroid culture of primary colorectal cancer cells as an in\u00a0vitro model for personalizing cancer medicine","volume":"12","author":"Jeppesen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clcc.2018.10.003_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-5956-12-39","article-title":"Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture","volume":"12","author":"Rajcevic","year":"2014","journal-title":"Proteome Sci"},{"key":"10.1016\/j.clcc.2018.10.003_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002817304954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002817304954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:05:28Z","timestamp":1761519928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002817304954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1533002817304954"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2018.10.003","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}